Abnormal NF-κB signaling and genetic mutations in NF-κB signaling-associated factors impact the tumorigenicity, proliferation, chemoresistance, and radioresistance of multiple kinds of cancers including NPC [38]. This evidence concerns the gene NFKB1 and cancer.